UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1571) 1571
Book Chapter (46) 46
Dissertation (21) 21
Conference Proceeding (13) 13
Publication (12) 12
Magazine Article (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (1067) 1067
life sciences & biomedicine (1030) 1030
humans (846) 846
flt3 (755) 755
hematology (519) 519
oncology (511) 511
acute myeloid leukemia (510) 510
mutation (436) 436
fms-like tyrosine kinase 3 - genetics (395) 395
animals (339) 339
leukemia (335) 335
female (329) 329
male (323) 323
leukemia, myeloid, acute - genetics (305) 305
mice (254) 254
hemic and lymphatic diseases (247) 247
middle aged (243) 243
tyrosine (242) 242
adult (241) 241
aml (239) 239
prognosis (217) 217
leukemia, myeloid, acute - drug therapy (199) 199
aged (183) 183
fms-like tyrosine kinase 3 (174) 174
fms-like tyrosine kinase 3 - antagonists & inhibitors (174) 174
cancer (169) 169
flt3 ligand (168) 168
fms-like tyrosine kinase 3 - metabolism (168) 168
kinases (158) 158
adolescent (150) 150
hemic and immune systems (145) 145
embryonic structures (144) 144
protein-tyrosine kinase (135) 135
flt3 protein (130) 130
chemotherapy (129) 129
analysis (127) 127
stem cells (127) 127
leukemia, myeloid, acute - pathology (120) 120
myeloid leukemia (119) 119
proto-oncogene proteins - genetics (114) 114
receptor protein-tyrosine kinases - genetics (110) 110
cell line, tumor (108) 108
immunology (106) 106
research (106) 106
protein kinase inhibitors - pharmacology (102) 102
biochemistry & molecular biology (100) 100
signal transduction (100) 100
cell biology (99) 99
genetic aspects (99) 99
fluids and secretions (97) 97
leukemia, myeloid, acute - metabolism (97) 97
tandem repeat sequences (97) 97
flow cytometry (93) 93
gene expression (93) 93
treatment outcome (93) 93
dendritic cells (92) 92
pharmacology & pharmacy (92) 92
transplantation (91) 91
acute disease (89) 89
antineoplastic agents - therapeutic use (89) 89
apoptosis (89) 89
bone marrow (89) 89
proteins (87) 87
child (86) 86
young adult (86) 86
aged, 80 and over (85) 85
antineoplastic agents - pharmacology (84) 84
leukemia, myeloid, acute - mortality (84) 84
health aspects (82) 82
hematopoietic stem cells (81) 81
phosphorylation (80) 80
protein kinase inhibitors - therapeutic use (79) 79
leukemia, myeloid - genetics (77) 77
flt3-itd (76) 76
mice, inbred c57bl (74) 74
npm1 (74) 74
cell proliferation (73) 73
dendritic cells - immunology (72) 72
leukemia, myeloid, acute - diagnosis (71) 71
ligands (70) 70
acute myeloid leukaemia (69) 69
hematology, oncology and palliative medicine (67) 67
medicine & public health (67) 67
gene duplication (66) 66
gene mutations (66) 66
leukemia, myeloid, acute - therapy (65) 65
medicine, research & experimental (65) 65
research & experimental medicine (65) 65
antineoplastic combined chemotherapy protocols - therapeutic use (64) 64
medical prognosis (64) 64
hematopoiesis (63) 63
patients (63) 63
cells, cultured (62) 62
flt3 gene (60) 60
child, preschool (59) 59
mutation - genetics (59) 59
recurrence (59) 59
retrospective studies (59) 59
sorafenib (58) 58
internal tandem duplication (57) 57
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1498) 1498
Chinese (149) 149
French (6) 6
Japanese (5) 5
Czech (4) 4
Turkish (3) 3
Breton (2) 2
Russian (2) 2
Spanish (2) 2
German (1) 1
Italian (1) 1
Korean (1) 1
Polish (1) 1
Portuguese (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Molecular cancer therapeutics, ISSN 1538-8514, 06/2017, Volume 16, Issue 6, pp. 991 - 1001
The receptor tyrosine kinase fms-like tyrosine kinase 3 (FLT3), involved in regulating survival, proliferation, and differentiation of hematopoietic... 
Life Sciences & Biomedicine | Oncology | Science & Technology | fms-Like Tyrosine Kinase 3 - antagonists & inhibitors | Leukemia, Myeloid, Acute - pathology | Humans | Protein Multimerization | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Treatment Outcome | Clinical Trials as Topic | Tandem Repeat Sequences | fms-Like Tyrosine Kinase 3 - chemistry | fms-Like Tyrosine Kinase 3 - metabolism | Leukemia, Myeloid, Acute - mortality | fms-Like Tyrosine Kinase 3 - genetics | Drug Resistance, Neoplasm - genetics | Animals | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Leukemia, Myeloid, Acute - drug therapy | Protein Binding | Protein Interaction Domains and Motifs | Protein Kinase Inhibitors - pharmacology | Mutation | Drug Evaluation, Preclinical | Leukemia, Myeloid, Acute - genetics | Cell proliferation | Tyrosine | Drugs | Medical research | Cell survival | Myeloid leukemia | Leukemia | Clinical trials | Kinases | Survival | Patients | Progenitor cells | Proteasome inhibitors | Hemopoiesis | Signaling | Chemotherapy | Inhibitors | Cells (biology) | Protein-tyrosine kinase receptors | Flt3 protein | Acute myeloid leukemia | Protein-tyrosine kinase | Cancer | Index Medicus | FLT3 internal tandem duplication | FLT3 point mutation | FLT3 inhibitors | acute myeloid leukemia | resistance
Journal Article
11/2013
Survival rates for pediatric B-cell acute lymphoblastic leukemia (B-ALL) have improved dramatically, but outcomes for the 15% who relapse and for adults with... 
RANKL | Flt3 | 0992
Dissertation
Cancer, ISSN 0008-543X, 07/2014, Volume 120, Issue 14, pp. 2142 - 2149
Journal Article
Journal of mammalian ova research, ISSN 1341-7738, 2014, Volume 31, Issue 1, pp. 45 - 51
Successful development of preimplantation embryos is essential for reproduction. Growth factors secreted by reproductive tracts are important for the... 
FLT3 ligand | Oviduct | Preimplantation embryo | Uterus | FLT3
Journal Article
Cancer, ISSN 0008-543X, 08/2017, Volume 123, Issue 15, pp. 2867 - 2874
Journal Article
Journal Article
Journal of controlled release, ISSN 0168-3659, 08/2020, Volume 324, pp. 317 - 329
FLT3 receptor is an important therapeutic target in acute myeloid leukemia due to high incidence of mutations associated with poor clinical outcome. Targeted... 
AML | ELP | FLT3 | Therapeutic target | Index Medicus
Journal Article
Leukemia & lymphoma, ISSN 1029-2403, 11/2017, Volume 59, Issue 10, pp. 2273 - 2286
Activating mutations in FMS-like tyrosine kinase 3 (FLT3), including internal tandem duplications (ITDs) and tyrosine kinase domain (TKD) mutations, are common... 
AML | prognostic | FLT3 tyrosine kinase inhibitor | predictive marker | FLT3 testing | Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology
Journal Article
Journal Article
European journal of medicinal chemistry, ISSN 0223-5234, 05/2020, Volume 193, pp. 112232 - 112232
Mutants of the FLT3 receptor tyrosine kinase (RTK) with duplications in the juxtamembrane domain (FLT3-ITD) act as drivers of acute myeloid leukemia (AML).... 
FLT3 D835Y | FLT3 | Tyrosine kinase inhibitor | Acute myeloid leukemia | FLT3-ITD | Index Medicus
Journal Article
Journal Article
Leukemia, ISSN 1476-5551, 01/2019, Volume 33, Issue 2, pp. 299 - 312
Journal Article